BMO Capital raised the firm’s price target on Skyward Specialty Insurance to $28 from $27 and keeps a Market Perform rating on the shares after its better than expected Q2 results. The upward revision is driven by an improving underlying loss ratio as the company continues to remix into a healthy pricing environment, plus a downward trend in its expense ratio due to operating leverage, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SKWD:
- Skyward Specialty Welcomes Gena Ashe to Board of Directors
- Skyward Specialty Insurance price target raised to $32 from $30 at JMP Securities
- Skyward Specialty Insurance reports Q2 adjusted EPS 42c , consensus 38c
- Skyward Specialty Insurance initiated with a Market Perform at BMO Capital
- Skyward Specialty Insurance price target raised to $30 from $28 at JMP Securities
